FDA Drug Safety Communication: Bisphosphonates and Esophageal Cancer
The U.S. Food and Drug Administration (FDA) is continuing to review data from published studies to evaluate whether use of oral bisphosphonate drugs is associated with an increased risk of cancer of the esophagus (esophageal cancer).
- (-) Remove Cancer filter Cancer
- (-) Remove Neuromuscular Disease filter Neuromuscular Disease
- (-) Remove Osteoporosis filter Osteoporosis